Skip to main content Skip to footer

NHS Lateral Flow Device (LFD) tests supply service for patients potentially eligible for COVID-19 treatments

The NHS LFD tests supply service for patients potentially eligible for COVID-19 treatments started on 6 November 2023. 

Aims of the service 

To offer eligible at-risk patients access to LFD tests to enable testing at home for COVID-19, if they develop symptoms of infection. A positive LFD test result will be used to inform a clinical assessment to determine whether the patient is suitable for and will benefit from NICE recommended COVID-19 treatments. 

What the service will provide 

A walk-in service where patients or their representatives can collect one box of 5 LFD tests from a participating community pharmacy on confirmation that the patient is part of the potentially eligible for COVID-19 treatments cohort. 

Service specification 

The service specification can be found on the NHS England website.